UNASSIGNED: Ten patients aged over 65 years with multiple vertebral metastases were enrolled in this study. Preoperatively, patients exhibited a median Visual Analog Scale (VAS) pain score of 6 and a Median Oswestry Disability Index (ODI) score of 58%. From February 2021 to April 2022, all patients underwent RFA, followed by vertebroplasty for spinal metastases. Surgical procedures were executed using the ExcelsiusGPS® robotic platform.
UNASSIGNED: Patients experienced substantial pain relief, with a median VAS score of 2.5 at 24 h postoperatively (Δ --3.5; P < 0.001) and a median VAS score of 2 at 1 month postoperatively (Δ -4; P < 0.001). All patients were discharged on the first postoperative day and continued their oncological treatments. In addition, the median ODI score at 1 month postoperatively was 34% (Δ --24%; P = 0.006), indicating an enhanced quality of life and a satisfactory impact on daily activities. No procedural or postoperative complications were documented.
UNASSIGNED: This case series represents the inaugural successful application of robot-assisted RFA in conjunction with concurrent vertebroplasty/kyphoplasty. Our preliminary experience demonstrates that patients with oligo- and polymetastatic conditions can derive benefits from this minimally invasive intervention, characterized by rapid postoperative recovery and effective short- to medium-term pain management, without encountering complications.
■本研究纳入了10例年龄超过65岁的多发性椎体转移患者。术前,患者的视觉模拟量表(VAS)疼痛评分中位数为6分,Oswestry残疾指数(ODI)评分中位数为58%.从2021年2月到2022年4月,所有患者都接受了RFA,其次是脊柱转移瘤的椎体成形术。使用ExcelsiusGPS®机器人平台执行外科手术。
■患者经历了实质性的疼痛缓解,术后24小时VAS评分中位数为2.5(Δ-3.5;P<0.001),术后1个月VAS评分中位数为2(Δ-4;P<0.001)。所有患者均在术后第一天出院,并继续进行肿瘤治疗。此外,术后1个月ODI评分中位数为34%(Δ-24%;P=0.006),表明生活质量提高,对日常活动产生令人满意的影响。无手术或术后并发症记录。
■该病例系列代表了机器人辅助RFA与同时进行的椎体成形术/椎体后凸成形术的首次成功应用。我们的初步经验表明,患有少和多转移性疾病的患者可以从这种微创干预中获益。其特点是术后快速恢复和有效的短期至中期疼痛管理,没有遇到并发症。